|

Surgery for Thyroid Cancer With or Without Autofluorescence to Prevent Hypoparathyroidism

RECRUITINGN/ASponsored by Aarhus University Hospital
Actively Recruiting
PhaseN/A
SponsorAarhus University Hospital
Started2024-01-01
Est. completion2027-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06222606

Summary

The study aims to test if use of autofluorescence imaging (AF) reduces the risk of developing hypoparathyroidism (hypoPT) following surgery for thyroid cancer, either total thyroidectomy (TT) or completion hemithyroidectomy (cHT).

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age\>18 years and able to give informed consent.
* Suspicion or diagnosis of thyroid cancer.
* Planned total thyroidectomy or completion thyroidectomy.
* Normocalcemia prior to surgery.

Exclusion Criteria:

* Planned simultaneous parathyroid surgery.
* Treatment with active vitamin D analogues.
* eGFR \< 30.

Conditions2

CancerThyroid Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.